The drugs have made headlines for their use among the glitterati, and have been provoking important conversations about how society views and treats people with higher weights
There were many improvements in risk factors for heart disease, blood sugar levels, and quality of life for these patients
[2] People with diabetes, particularly those on insulin, should also be aware of a potential risk of diabetic retinopathy complications, especially if blood glucose control improves rapidly
Employer Implications As oral nonpeptide GLP1s and combination therapies approach market entry, plan sponsors should anticipate expanded utilization, increased clinical complexity and heightened pressure on costcontainment strategies
Mounjaro itself doesnt directly affect bones
As the popularity of GLP-1 drugs fof weight loss continues to grow, understanding the short- and long-term side effects of these medications is just as important as measuring pounds lost on a scale